NCT05604729 is a NA clinical trial of Botulinum toxin type A in Tooth Wear, sponsored by Region Västerbotten.

Who is sponsoring NCT05604729?

NCT05604729 is sponsored by Region Västerbotten.

What drugs are being tested in NCT05604729?

Interventions in NCT05604729: Botulinum toxin type A, Placebo.

What condition does NCT05604729 study?

NCT05604729 studies Tooth Wear, Bruxism.

Is NCT05604729 still recruiting?

NCT05604729 is currently status unknown. Last updated 3 May 2023.

Last reviewed 2023-05-03 · How we verify

NCT05604729

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect on Envelope of Motion in Asymptomatic Bruxers

Status unknown NA Last updated 3 May 2023

What this trial tests

NA trial testing Botulinum toxin type A in Tooth Wear in 60 participants. Status unknown.

Timeline

1 September 2023

Primary endpoint
31 December 2024

31 December 2025

Quick facts

Lead sponsor	Region Västerbotten
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	60
Start date	1 September 2023
Primary completion	31 December 2024
Estimated completion	31 December 2025
Sites	1 location across Sweden

Drugs / interventions tested

Botulinum toxin type A (BOTULINUM TOXIN TYPE A) — full drug profile →
Placebo

Conditions studied

Tooth Wear — all drugs for Tooth Wear →
Bruxism — all drugs for Bruxism →

Sponsor

Region Västerbotten — full company profile →

Who can join

25 and older, any sex, with Tooth Wear or Bruxism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigating the effect of botulinum neurotoxin on the jaw-neck envelope of motion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Botulinum toxin type A

Trials testing the same drug.

NCT07236632 — Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized S · NA · not yet recruiting
NCT06448676 — Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides · Phase 4 · not yet recruiting
NCT06296082 — Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Sp · Phase 2, PHASE3 · recruiting
NCT06385171 — Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation · recruiting
NCT06465056 — Use of Botulinum Toxin A in Direct Eyebrow Lift Scar · Phase 2 · recruiting

Other recruiting trials for Tooth Wear

Currently open trials in the same condition.

NCT07276269 — Survival and Success of CAD/CAM Restorations After 5 Years of Intraoral Use · NA · active not recruiting
NCT06125132 — Evaluation of 2-year Clinical Performance of Two Different Single Color Universal Composite Resin Restorative Materials. · NA · active not recruiting
NCT04481087 — Clinical Comparison of Different Adhesives in NCCLs · NA · active not recruiting

Other Region Västerbotten trials

Trials by the same sponsor.

NCT06330116 — Different Forms of OMT as Methods for Reducing Snoring and Mild to Moderate Sleep Apnea · NA · enrolling by invitation
NCT06717061 — Composed Abdominal Wall Analysis. Collecting Tissue and Blood From Patients Undergoing Elective Laparosopic Cholecystect · enrolling by invitation
NCT05353829 — Methotrexate in Patients with Early Rheumatoid Arthritis · Phase 4 · active not recruiting
NCT05309564 — Muscle Weakness Duration After Single Botulinum Toxin Injection in Masseter · NA · completed
NCT03925363 — A Mobile Application to Increase Physical Activity · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05604729 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Region Västerbotten
Last refreshed: 3 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05604729.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing